Trending
- Favezelimab Combo Boosts PFS vs Chemo in PD-1–Refractory Hodgkin Lymphoma
- Ziftomenib Plus 7+3 Yields High Response Rates in Newly Diagnosed AML
- Liso-Cel Demonstrates Real-World Efficacy in Relapsed/Refractory MCL
- A computational framework for optimizing radioiodine therapy protocols in metastatic thyroid cancer
- London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’ | Pharmaceuticals industry
- ERO1a fosters glioblastoma aggressiveness and metabolic flexibility by regulating mitochondria-associated membrane dynamics
- NHS staff battling wave of food supplement disinformation | NHS
- Tumour deposits in colorectal carcinoma are associated with immune evasion and dose-dependent adverse prognosis beyond nodal status
Sunday, June 14